Lying Positions in Intramuscular Injection
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Lying before procedure.
- Who it may be relevant to
- Registry conditions: Ventrogluteal Injections. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Three Different Lying Positions on Pain, Comfort, and Satisfaction Levels in Intramuscular Injection: A Randomized Controlled Trial
Overview
The aim of this study is to examine the effects of intramuscular (IM) injections administered in three different lying positions (supine, prone, and lateral) into the ventrogluteal site on patient pain, comfort, and procedural satisfaction. The study will be conducted as a randomized controlled experimental trial with three groups. In Experimental Group 1, patients will be placed in the supine position; in Experimental Group 2, the lateral position; and in Experimental Group 3, the prone position prior to the injection procedure, followed by an IM injection into the ventrogluteal site. Subsequent to the procedure, patients' pain, comfort, and procedural satisfaction levels will be assessed.
Interventions
- Procedure Lying before procedure
Lying position before intramuscular injection
Primary outcome measures
- Visual Analog Scale (VAS) Score for Pain [Time frame: during the procedure]
Secondary outcome measures (2)
- Procedural Satisfaction Score [Time frame: during the procedure]
- Patient Comfort Level [Time frame: During the procedure]
Eligibility criteria
Inclusion criteria
- Being 18 years of age or older,
- Having received an IM injection at least one week prior to the study,
- Absence of scars, ecchymosis, or hematomas at the injection site,
- Having a BMI between 18.5 and 24.9 kg/m²,
- Absence of lower extremity paralysis,
- Not receiving any oral or parenteral analgesic treatment prior to the injection.
Exclusion criteria
- Failure of the patient to respond to the questions in the post-procedure data collection form.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Screening
Study locations
Turkey (Türkiye) · 1 center
- Yalova University — Yalova
Identifiers
NCT: NCT07586605 · 2026/208